Summary & Overview
HCPCS A6010: Collagen-Based Wound Filler, Dry Sterile Per Gram
HCPCS Level II code A6010 represents a sterile, dry-form, collagen-based wound filler billed per gram of collagen. This code identifies an implantable or topical wound management product used to fill wound cavities and support tissue regeneration in acute and chronic wounds. Its classification as an HCPCS Level II supply code ensures standardized reporting for coverage and claims processing across medical benefit settings.
Key national payers include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage and reimbursement policies vary by payer and by site of service, with distinct medical necessity and documentation requirements that can affect payment for wound care supplies.
Readers will learn the clinical context for use of A6010, typical sites of service, and what to expect in payer coverage approaches. The publication provides benchmarks and payer policy overviews, summarizes common billing considerations, and outlines clinical scenarios where a collagen-based wound filler is applied. Data not available in the input will be indicated where relevant.
Billing Code Overview
HCPCS Level II code A6010 describes a collagen-based wound filler, dry form, sterile, per gram of collagen. This product is used as a wound care adjunct to fill wound cavities, support tissue regeneration, and provide a scaffold for healing.
-
Service type: Wound care product application and management
-
Typical site of service: Outpatient wound care clinics, hospital outpatient departments, long-term care facilities, and other settings where topical wound management is provided
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult with a chronic, non-healing soft tissue wound (for example a stage III pressure ulcer or a diabetic foot ulcer) presenting to a wound care clinic or outpatient surgery center for advanced wound management. After wound assessment, debridement, infection control, and optimization of perfusion, the clinician measures the defect and determines that a biologic scaffold is indicated to fill dead space and support granulation. A sterile, dry-form, collagen-based wound filler billed with code A6010 is prepared in grams and applied directly into the wound bed at the time of the procedure. The clinical workflow commonly includes wound measurement and photography, sharp or enzymatic debridement (if needed), irrigation, application of the collagen powder or granules A6010 in the appropriate gram quantity, placement of a secondary dressing or negative pressure wound therapy, documentation of grams used, and patient instructions for dressing changes and follow-up in the wound clinic. Typical sites of service are outpatient wound care clinics, ambulatory surgery centers, hospital outpatient departments, and skilled nursing facilities when sterile application is required. Typical patients include those with chronic diabetic ulcers, pressure injuries, venous stasis ulcers, surgical dehiscence with tissue loss, or traumatic soft tissue defects requiring biologic filler to promote granulation and wound closure.
Coding Specifications
Modifier 00 is a payer/system placeholder and is rarely appended clinically; included in the raw list. Below are the most clinically relevant modifiers for A6010.
| Modifier |
|---|